Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

59.20
+2.314.06%
Post-market: 59.200.00000.00%18:46 EDT
Volume:6.76M
Turnover:399.40M
Market Cap:4.55B
PE:65.05
High:59.77
Open:57.42
Low:56.56
Close:56.89
52wk High:61.12
52wk Low:26.27
Shares:76.85M
Float Shares:35.24M
Volume Ratio:8.67
T/O Rate:19.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9100
EPS(LYR):0.7500
ROE:13.74%
ROA:8.18%
PB:7.51
PE(LYR):78.93

Loading ...

US High Growth Tech Stocks to Watch

Simply Wall St.
·
Jun 24

Kiniksa Pharmaceuticals International (KNSA) Stock Could Be 18% Undervalued After Strong Buy Upgrade

Simply Wall St.
·
Jun 17

Kiniksa Pharmaceuticals held annual shareholder meeting

Reuters
·
May 30

Kiniksa Pharma to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 30

Kiniksa shareholders waive share conversion rights above 49.9% voting stake

Reuters
·
May 27

Kiniksa Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 09

Kiniksa publishes 2025 annual report

Reuters
·
May 09

Kiniksa CMO John F. Paolini disposes 58,424 shares for $3.15 million

Reuters
·
May 06

Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor

TIPRANKS
·
May 02

Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role

Reuters
·
May 02

Kiniksa CEO Sanj K Patel disposes of 486,339 shares for $25.23 million

Reuters
·
May 01

Kiniksa Pharmaceuticals’ Mine Safety Disclosure: No Incidents Reported but Transparency Gaps Remain for Investors

TIPRANKS
·
Apr 30

Kiniksa director Barry Quart sells 13,099 shares for $656,812.9

Reuters
·
Apr 30

Kiniksa Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 30

Canaccord Genuity Reaffirms Their Buy Rating on Kiniksa Pharmaceuticals (KNSA)

TIPRANKS
·
Apr 29

Kiniksa Pharmaceuticals International Plc : Wells Fargo Raises Target Price to $57 From $53

THOMSON REUTERS
·
Apr 29

Kiniksa Pharmaceuticals Is Maintained at Buy by Jefferies

Dow Jones
·
Apr 29

Kiniksa price target raised to $71 from $58 at Jefferies

TIPRANKS
·
Apr 29

Kiniksa Pharmaceuticals Up Over 20%, on Track for Record High Close -- Data Talk

Dow Jones
·
Apr 29

Wedbush Lifts Price Target on Kiniksa Pharmaceuticals International to $59 From $58, Maintains Outperform Rating

MT Newswires Live
·
Apr 28